High-energy ball milling of saquinavir increases permeability across the buccal mucosa

References

• Naidoo P. Barriers to HIV care and treatment by doctors: a review of the literature. S.A Fam Prac 2006;48:55a–e
   Google Scholar
• Rathbun RC, Lockhart SM, Stephens JR. Current HIV treatment guidelines—an overview. Curr Pharm Des 2006;12:1045–63
   PubMed Web of Science ®Google Scholar
• Sharma P, Garg S. Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. Adv Drug Deliv Rev 2010;62:491–502
   PubMed Web of Science ®Google Scholar
• Williams GC, Sinko PJ. Oral absorption of the HIV protease inhibitors: a current update. Adv Drug Deliv Rev 1999;39:211–38
   PubMed Web of Science ®Google Scholar
• Senel S, Hincal AA. Drug permeation enhancement via buccal route: possibilities and limitations. J Control Release 2001;72:133–44
   PubMed Web of Science ®Google Scholar
• Hassan N, Ahad A, Ali M, Ali J. Chemical permeation enhancers for transbuccal drug delivery. Expert Opin Drug Deliv 2010;7:97–112
   PubMed Web of Science ®Google Scholar
• Sandri G, Rossi S, Bonferoni MC, et al. Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule. Int J Pharm 2005;297:146–55
   PubMed Web of Science ®Google Scholar
• Sohi H, Ahuja A, Ahmad FJ, Khar RK. Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev Ind Pharm 2010;36:254–82
   PubMed Web of Science ®Google Scholar
• Kaus LC, Gillespie WR, Hussain AS, Amidon GL. The effect of in vivo dissolution, gastric emptying rate, and intestinal transit time on the peak concentration and area-under-the-curve of drugs with different gastrointestinal permeabilities. Pharm Res 1999;16:272–80
   PubMed Web of Science ®Google Scholar
• Squier CA, Hall BK. The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier. J Invest Dermatol 1985;84:176–9
   PubMed Web of Science ®Google Scholar
• Rathbone MJ, Drummond BK, Tucker IG. The oral cavity as a site for systemic drug delivery. Adv Drug Deliv Rev 1994;13:1–22
   Web of Science ®Google Scholar
• Squier CA, Wertz PW. Structure and function of the oral mucosa and implications for drug delivery. In: Rathbone MJ, Swarbrick J, eds. Oral mucosal drug delivery. NY: Marcel Dekker, Inc.; 1996:1–26
   Google Scholar
• Salamat-Miller N, Chittchang M, Johnston TP. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev 2005;57:1666–91
   PubMed Web of Science ®Google Scholar
• Shojaei AH. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharm Sci 1998;1:15–30
   PubMedGoogle Scholar
• Mukherji E, Millenbaugh NJ, Au JL. Percutaneous absorption of 2′,3′-dideoxyinosine in rats. Pharm Res 1994;11:809–15
   PubMed Web of Science ®Google Scholar
• Narishetty ST, Panchagnula R. Effect of L-menthol and 1,8-cineole on phase behavior and molecular organization of SC lipids and skin permeation of zidovudine. J Control Release 2005;102:59–70
   PubMed Web of Science ®Google Scholar
• Raghavendra C, Mundargi VRB, Vidhya R, Tejraj MA. Formulation and in vitro evaluation of transdermal delivery of zidovudine—an anti-HIV drug. J Appl Polym Sci 2009;119:1268–74
   Web of Science ®Google Scholar
• Suwanpidokkul N, Thongnopnua P, Umprayn K. Transdermal delivery of zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin. AAPS PharmSciTech 2004;5:82–9
   Google Scholar
• Ojewole E, Mackraj I, Akhundov K, et al. Investigating the effect of aloe vera gel on the buccal permeability of didanosine. Planta Med 2012;78:354–61
   PubMed Web of Science ®Google Scholar
• Xiang J, Fang X, Li X. Transbuccal delivery of 2′,3′-dideoxycytidine: in vitro permeation study and histological investigation. Int J Pharm 2002;231:57–66
   PubMed Web of Science ®Google Scholar
• Branham ML, Moyo T, Govender T. Prepartion and solid-state characterization of ball milled saquinavir mesylate for solubility enhancement. Eur J Pharm Biopharm 2012;80:194–202
   PubMed Web of Science ®Google Scholar
• Fitzsimmons ME, Collins JM. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small intestinal cytochrome P4503A4. Potential contribution to high first-pass metabolism. Drug Metab Dispos 1997;25:256–66
   PubMed Web of Science ®Google Scholar
• Eagling VA, Back DJ, Barry MG. Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. Br J Clin Pharm 1997;44:190–4
   PubMed Web of Science ®Google Scholar
• Palanisamy M, Khanam J. Solid dispersion of prednisolone: solid state characterization and improvement of dissolution profile. Drug Dev Ind Pharm 2011;37:373–86
   PubMed Web of Science ®Google Scholar
• Dave RH, Patel HH, Donahue E, Patel AD. To evaluate the change in release from solid dispersion using sodium lauryl sulfate and model drug sulfathiazole. Drug Dev Ind Pharm 2013;39:1562–72
   PubMed Web of Science ®Google Scholar
• Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 2003;18:113–20
   PubMed Web of Science ®Google Scholar
• Chiappetta DA, Hocht C, Taira C, Sosnik A. Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability. Nanomedicine 2010;5:11–13
   PubMed Web of Science ®Google Scholar
• Chen H, Khemtong C, Yang X, et al. Nanonization strategies for poorly water-soluble drugs. Drug Discov Today 2011;16:354–60
   PubMed Web of Science ®Google Scholar
• Gao L, Liu G, Ma J, et al. Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs. Pharm Res 2013;30:307–24
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60
   PubMed Web of Science ®Google Scholar
• Yin L, Huang S, Zhu C, et al. In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier. Drug Dev Ind Pharm 2012;38:1371–80
   PubMed Web of Science ®Google Scholar
• Ayad MH, Bonnet B, Quinton J, et al. Amorphous solid dispersion successfully improved oral exposure of ADX71943 in support of toxicology studies. Drug Dev Ind Pharm 2013;39:1300–5
   PubMed Web of Science ®Google Scholar
• Caron V, Hu Y, Tajber L, et al. Amorphous solid dispersions of sulfonamide/soluplus and sulfonamide/PVP prepared by ball milling. AAPS PharmSciTech 2013;14:464–74
   PubMed Web of Science ®Google Scholar
• Al-Obaidi H, Lawrence MJ, Al-Sadan N, Ke P. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions. Int J Pharm 2013;443:95–102
   PubMedGoogle Scholar
• Rambharose S, Ojewole E, Mackraj I, Govender T. Comparative buccal permeability enhancement of didanosine and tenofovir by potential multifunctional polymeric excipients and their effects on porcine buccal histology. Pharm Dev Technol 2013;19:82–90
   Google Scholar
• Jones E, Ojewole E, Pillay V, et al. Monolayered multipolymeric buccal films with drug and polymers of opposing solubilities for ARV therapy: physico-mechanical evaluation and molecular mechanics modeling. Int J Pharm 2013;455:197–212
   PubMed Web of Science ®Google Scholar
• Chen W, Lu Z, Viljoen A, Hamman J. Intestinal drug transport enhancementby Aloe vera. Planta Med 2009;75:587–95
   PubMed Web of Science ®Google Scholar
• Karnovsky MJ. A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J Cell Biol 1965;27:137–8
   Web of Science ®Google Scholar
• Heemstra LB, Finnin BC, Nicolazzo JA. The buccal mucosa as an alternative route for the systemic delivery of risperidone. J Pharm Sci 2010;99:4584–92
   PubMed Web of Science ®Google Scholar
• Hu L, Damaj BB, Martin R, Michniak-Kohn BB. Enhanced in vitro transbuccal drug delivery of ondansetron HCl. Int J Pharm 2011;404:66–74
   PubMed Web of Science ®Google Scholar
• Mahalingam R, Ravivarapu H, Redkar S, et al. Transbuccal delivery of 5-aza-2′-deoxycytidine: effects of drug concentration, buffer solution, and bile salts on permeation. AAPS PharmSciTech 2007;8:28–33
   PubMed Web of Science ®Google Scholar
• Sethia S, Squillante E. Solid dispersions: revival with greater possibilities and applications in oral drug delivery. Crit Rev Ther Drug Carrier Syst 2003;20:215–47
   PubMed Web of Science ®Google Scholar
• Heinz A, Strachan CJ, Atassi F, et al. Characterizing an amorphous system exhibiting trace crystallinity: a case study with saquinavir. Crystal Growth Des 2008;8:119–27
   Web of Science ®Google Scholar
• Brittain HG. Effects of mechanical processing on phase composition. J Pharm Sci 2002;91:1573–80
   PubMed Web of Science ®Google Scholar
• Royall PG, Craig DQM, Doherty C. Characterization of moisture uptake effects on the glass transitional behavior of an amorphous drug using modulated temperature DSC. Int J Pharm 1999;192:39–46
   PubMedGoogle Scholar
• Singare DS, Marella S, Gowthamarajan K, et al. Optimization of formulation and process variable of nanosuspension: an industrial perspective. Int J Pharm 2010;402:213–20
   PubMed Web of Science ®Google Scholar
• Kaushal AM, Gupta P, Bansal AK. Amorphous drug delivery systems: molecular aspects, design, and performance. Crit Rev Ther Drug Carrier Syst 2004;21:133–93
   PubMedGoogle Scholar
• Desprez S, Descamps M. Transformation of glassy indomethacin by ballmilling. J Non-Cryst Solids 2006;352:4480–5
   Web of Science ®Google Scholar
• Hancock B, Parks M. What is the solubility advantage for amorphous pharmaceuticals. Pharm Res 2000;17:397–404
   PubMed Web of Science ®Google Scholar
• Dhiman M, Dhiman A, Sawant K. Transbuccal delivery of 5-fluorouracil: permeation enhancement and pharmacokinetic study. AAPS PharmSciTech 2009;10:258–65
   PubMed Web of Science ®Google Scholar
• Figueiras A, Hombach J, Veiga F, Bernkop-Schnurch A. In vitro evaluation of natural and methylated cyclodextrins as buccal permeation enhancing system for omeprazole delivery. Eur J Pharm Biopharm 2009;71:339–45
   PubMed Web of Science ®Google Scholar
• Muendoerfer M, Schaefer UF, Koenig P, et al. Online monitoring of transepithelial electrical resistance (TEER) in an apparatus for combined dissolution and permeation testing. Int J Pharm 2010;392:134–40
   PubMed Web of Science ®Google Scholar
• Nielsen HM, Rassing MR. Nicotine permeability across the buccal TR146 cell culture model and porcine buccal mucosa in vitro: effect of pH and concentration. Eur J Pharm Sci 2002;16:151–7
   PubMed Web of Science ®Google Scholar
• Kowapradit J, Opanasopit P, Ngawhirunpat T, et al. In vitro permeability enhancementin intestinal epithelial cells (Caco-2) monolayer of water soluble quaternaryammonium chitosan derivatives. AAPS PharmSciTech 2010;11:497–508
   PubMed Web of Science ®Google Scholar
• Nicolazzo JA, Reed BL, Finnin BC. Buccal penetration enhancers—how do they really work? J Control Release 2005;105:1–15
   PubMed Web of Science ®Google Scholar
• Hoogstraate JAJ, Wertz PW. Drug delivery via the buccal mucosa. Pharm Sci Technol Today 1998;1:309–16
   Google Scholar
• Madhav NVS, Shakya AK, Shakya P, Singh K. Orotransmucosal drug delivery systems: a review. J Control Release 2009;140:2–11
   PubMed Web of Science ®Google Scholar